Reduction in antidrug antibody levels after switching to rituximab in patients with rheumatoid arthritis with prior infliximab or adalimumab secondary failure

Semin Arthritis Rheum. 2020 Feb;50(1):E1-E2. doi: 10.1016/j.semarthrit.2019.06.021. Epub 2019 Jun 28.

¹ Immuno-Rheumatology group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain; Immunology Unit, La Paz University Hospital, Madrid, Spain. Electronic address: [email protected].
² Immuno-Rheumatology group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain; Rheumatology Department, La Paz University Hospital, Madrid, Spain.
³ Immuno-Rheumatology group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain.
⁴ Immunology Unit, La Paz University Hospital, Madrid, Spain.
⁵ Rheumatology Department, La Paz University Hospital, Madrid, Spain.

No abstract available

Keywords: Antidrug antibodies; Rheumatoid arthritis; Rituximab.

Publication types